Sfoglia per AUTORE
CATTRAN D
Collezione ASL Torino 4

  

Items : 6

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. in Nature genetics / Nat Genet. 2023 Jul;55(7):1091-1105. doi: 10.1038/s41588-023-01422-x. Epub 2023 Jun 19.

2023
AOU Città della Salute di Torino
ASL Torino 4

Abeygunaratne T; Kiryluk K; Gharavi AG; Gale DP; Sanchez-Rodriguez E; Zhang H; Novak J; Julian BA; Ionita-Laza I; Köttgen A; Kenny EE; Ekici AB; Eckardt KU; Chen N; Xie J; Lifton RP; Loos RJF; Floege J; Schlosser P; Rauen T; Panzer U; Scolari F; Lundberg S; Vogt B; Mani LY; Huerta A; Barratt J; Appel GB; Harley JB; et alii...

Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy. in Journal of the American Society of Nephrology : JASN / J Am Soc Nephrol. 2021 Feb;32(2):436-447. doi: 10.1681/ASN.2020030349. Epub 2020 Dec 23.

2021
AOU Città della Salute di Torino
ASL Città di Torino
ASL Torino 4
ASL Biella
ASL Novara

Cattran D; Reich HN; Katafuchi R; Suzuki Y; Matsuzaki K; Liu ZH; Zhang H; Coppo R; Zheng Y; Barbour SJ; Canney M;

GWAS defines pathogenic signaling pathways and prioritizes drug targets for IgA nephropathy in medRxiv

2021
ASL Torino 4

Kiryluk K; Sanchez-Rodriguez E; Zhou X-J; Zanoni F; Liu L; Mladkova N; Khan A; Marasa M; Zhang JY; Balderes O; Sanna-Cherchi S; Bomback AS; Canetta PA; Appel GB; Radhakrishnan J; Trimarchi H; Sprangers B; Cattran DC; Reich H; Pei Y; Ravani P; Galesic K; Maixnerova D; Tesar V; Stengel B; Metzger M; Canaud G; Maillard N; Berthoux F; et alii...

The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. in Nature communications / Nat Commun. 2020 Mar 30;11(1):1600. doi: 10.1038/s41467-020-15383-w.

2020
ASL Città di Torino
ASL Torino 4
AOU Città della Salute di Torino

Zhang JY; Krithivasan P; Mehl K; Marasa M; Khan A; Ozay F; Canetta PA; Bomback AS; Kiryluk K; Chen N; Kleta R; Gharavi AG; Zhao MH; Scolari F; Brenchley P; Hoxha E; Stahl RAK; Cucca F; Ionita-Laza I; Lee H; Debiec H; Ronco P; Zoledziewska M; Wetzels JFM; Stengel B; Beck LH; Kretzler M; Akilesh S; Kiemeney LA; et alii...

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association / Nephrol Dial Transplant. 2020 Jun 1;35(6):1002-1009. doi: 10.1093/ndt/gfy302.

2020
ASL Biella
ASL Torino 4
AOU Città della Salute di Torino
ASL Torino 5
ASL Novara

Mallamaci F; Floege J; Egido J; Cravero R; Lino Cirami C; Fellstrom B; Quaglia M; Balafa O; D'Amico M; Ots-Rosenberg M; Geddes C; Topaloglu R; Maggio M; Benozzi L; Cusinato S; Berg U; Stangou M; Galesic K; Toric L; Papagianni A; Goumenos D; Papasotiriou M; Wetzels JFM; Ballarin JC; Moggia E; Durlik M; Caliskan Y; Perkowska-Ptasinska A; Pierucci A; et alii...

Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort. in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association / Nephrol Dial Transplant. 2019 Oct 1;34(10):1681-1690. doi: 10.1093/ndt/gfy337.

2019
ASL Torino 4
AOU Città della Salute di Torino
ASL Novara

Tardanico R; Stoppacciaro A; Sundelin Von Feilitzen B; Steenbergen E; Riispere Z; Soderberg MP; Perkowska-Ptasinska A; Ozluk Y; Pantzaki A; Mazzucco G; Orhan D; Kipgen D; Maldyk J; Karkoszka H; Ioachim E; Honsova E; Gutiérrez E; Asma Haider S; Gröne HJ; Gomà M; Giannakakis K; Furci L; Gakiopoulou H; Galesic Ljubanovic D; Fortunato M; Casartelli D; Maria Di Palma A; Ferrario F; Cannata-Ortiz P; et alii...